Clinical results of rifampicin treatment.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002207:Capreomycin / Q000627:therapeutic use; D002908:Chronic Disease; D004338:Drug Combinations; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D010118:Oxytetracycline / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D011859:Radiography; D012293:Rifampin / Q000627:therapeutic use*; D013183:Sputum / Q000382:microbiology; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology
D004338:Drug Combinations; D002207:Capreomycin; D011718:Pyrazinamide; D007612:Kanamycin; D004977:Ethambutol; D012293:Rifampin; D010118:Oxytetracycline